In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Veracyte Inc (NASDAQ: VCYT) closed the day trading at $29.00 down -0.68% from the previous closing price of $29.20. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
For a better understanding of VCYT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.95. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 5.10. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on March 20, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On December 05, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $38 to $37.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.Wolfe Research initiated its Outperform rating on November 15, 2024, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Leite John sold 7,411 shares for $31.66 per share. The transaction valued at 234,630 led to the insider holds 100,249 shares of the business.
JOHN LEITE bought 7,411 shares of VCYT for $240,932 on Mar 07 ’25. On Mar 04 ’25, another insider, ANN MCGUIRE, who serves as the Officer of the company, bought 1,142 shares for $33.56 each.
Valuation Measures:
As of this moment, Veracyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 69.13, and their Forward P/E ratio for the next fiscal year is 41.08. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.90 while its Price-to-Book (P/B) ratio in mrq is 1.90.
Stock Price History:
Over the past 52 weeks, VCYT has reached a high of $47.32, while it has fallen to a 52-week low of $19.73. The 50-Day Moving Average of the stock is -5.71%, while the 200-Day Moving Average is calculated to be -17.65%.
Shares Statistics:
A total of 78.31M shares are outstanding, with a floating share count of 77.20M. Insiders hold about 1.42% of the company’s shares, while institutions hold 108.39% stake in the company.
